A carregar...
Protein Aggregation and Immunogenicity of Biotherapeutics
Recombinant proteins are the mainstay of biopharmaceuticals. A key challenge in the manufacturing and formulation of protein biologic products is the tendency for the active pharmaceutical ingredients to aggregate, resulting in irreversible drug loss, and an increase in immunogenicity risk. While th...
Na minha lista:
| Publicado no: | Int J Pharm |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7362938/ https://ncbi.nlm.nih.gov/pubmed/32531452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpharm.2020.119523 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|